Global Entyvio (vedolizumab) Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 155161
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 107
  • list Medical Devices

Vedolizumab is a monoclonal antibody medicine developed by Takeda Pharmaceuticals for the treatment of ulcerative colitis and Crohn’s disease.

Scope of the Report:

This report focuses on the Entyvio (vedolizumab) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Entyvio (vedolizumab) Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Takeda

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Type 1

Type 2

Market Segment by Applications, can be divided into

Ulcerative Colitis

Crohn's Disease

There are 15 Chapters to deeply display the global Entyvio (vedolizumab) Drug market.

Chapter 1, to describe Entyvio (vedolizumab) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Entyvio (vedolizumab) Drug, with sales, revenue, and price of Entyvio (vedolizumab) Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Entyvio (vedolizumab) Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Entyvio (vedolizumab) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Entyvio (vedolizumab) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Entyvio (vedolizumab) Drug Introduction

1.2 Market Analysis by Type

1.2.1 Type 1

1.2.2 Type 2

1.3 Market Analysis by Applications

1.3.1 Ulcerative Colitis

1.3.2 Crohn's Disease

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Takeda

2.1.1 Business Overview

2.1.2 Entyvio (vedolizumab) Drug Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Entyvio (vedolizumab) Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017

3.3.2 Top 6 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Entyvio (vedolizumab) Drug Market Analysis by Regions

4.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Regions

4.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Regions (2013-2018)

4.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Regions (2013-2018)

4.2 North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.3 Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.5 South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

5 North America Entyvio (vedolizumab) Drug by Countries

5.1 North America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

5.1.1 North America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

5.1.2 North America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

5.2 United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

5.3 Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

5.4 Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6 Europe Entyvio (vedolizumab) Drug by Countries

6.1 Europe Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

6.1.1 Europe Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

6.2 Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.3 UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.4 France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.5 Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.6 Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7 Asia-Pacific Entyvio (vedolizumab) Drug by Countries

7.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

7.2 China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.3 Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.4 Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.5 India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

8 South America Entyvio (vedolizumab) Drug by Countries

8.1 South America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

8.1.1 South America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

8.1.2 South America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

8.3 Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

8.4 Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9 Middle East and Africa Entyvio (vedolizumab) Drug by Countries

9.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.3 UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.4 Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.5 Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.6 South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

10 Global Entyvio (vedolizumab) Drug Market Segment by Type

10.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Type (2013-2018)

10.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Type (2013-2018)

10.2 Type 1 Sales Growth and Price

10.2.1 Global Type 1 Sales Growth (2013-2018)

10.2.2 Global Type 1 Price (2013-2018)

10.3 Type 2 Sales Growth and Price

10.3.1 Global Type 2 Sales Growth (2013-2018)

10.3.2 Global Type 2 Price (2013-2018)

11 Global Entyvio (vedolizumab) Drug Market Segment by Application

11.1 Global Entyvio (vedolizumab) Drug Sales Market Share by Application (2013-2018)

11.2 Ulcerative Colitis Sales Growth (2013-2018)

11.3 Crohn's Disease Sales Growth (2013-2018)

12 Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)

12.2 Entyvio (vedolizumab) Drug Market Forecast by Regions (2018-2023)

12.2.1 North America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.2 Europe Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.3 Asia-Pacific Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.4 South America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.5 Middle East and Africa Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.3 Entyvio (vedolizumab) Drug Market Forecast by Type (2018-2023)

12.3.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)

12.3.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)

12.4 Entyvio (vedolizumab) Drug Market Forecast by Application (2018-2023)

12.4.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)

12.4.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Entyvio (vedolizumab) Drug Picture

Table Product Specifications of Entyvio (vedolizumab) Drug

Figure Global Sales Market Share of Entyvio (vedolizumab) Drug by Types

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery